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Equine herpesvirus type 1 (EHV-1) causes respiratory disorders and abortion in equids
while EHV-1 regularly causes equine herpesvirus myeloencephalopathy (EHM), a stroke-
like syndrome following endothelial cell infection in horses. Both EHV-1 and EHV-9 infec-
tions of non-definitive hosts often result in neuronal infection and high case fatality rates.
Hence, EHV-1 and EHV-9 are somewhat unusual herpesviruses and lack strict host speci-
ficity, and the true extent of their host ranges have remained unclear. In order to determine
the seroprevalence of EHV-1 and EHV-9, a sensitive and specific peptide-based ELISA
was developed and applied to 428 sera from captive and wild animals representing 30 spe-
cies in 12 families and five orders. Members of the Equidae, Rhinocerotidae and Bovidae
were serologically positive for EHV-1 and EHV-9. The prevalence of EHV-1 in the sampled
wild zebra populations was significantly higher than in zoos suggesting captivity may reduce
exposure to EHV-1. Furthermore, the seroprevalence for EHV-1 was significantly higher
than for EHV-9 in zebras. In contrast, EHV-9 antibody prevalence was high in captive and
wild African rhinoceros species suggesting that they may serve as a reservoir or natural
host for EHV-9. Thus, EHV-1 and EHV-9 have a broad host range favoring African herbi-
vores and may have acquired novel natural hosts in ecosystems where wild equids are
common and are in close contact with other perissodactyls.
Introduction
The order Perissodactyla includes the three families Equidae, Rhinocertidae, and Tapiridae. In
the Equidae, nine herpesviruses have been identified, six of which are allocated to the subfamily
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Alphaherpesvirinae and three in the subfamily Gammaherpesvirinae. EHV-1 is an alphaherpes-
virus and arguably one of the most important equine pathogens with a worldwide distribution
in domestic horses (Equus ferus caballus) in which it causes respiratory disease, abortion, neo-
natal death and neurological disorders [1]. Infections with EHV-1 or closely related viruses
have been identified in other equids including zebras, domestic donkeys, and onagers [2–4].
Among non-equid perissodactyls, EHV-1 infection was reported in the Indian tapir (Tapirus
indicus) and black rhinoceros (Diceros bicornis) [5, 6]. EHV-1 antibodies were detected with a
prevalence of 8.8% in African white (Ceratotherium simum) and black (Diceros bicornis) rhi-
noceroses [5].
EHV-9, the most recently discovered equine alphaherpesvirus, was first described in captive
Thomson’s gazelle (Gazelle thomsoni) in Japan that suffered from neurological symptoms and
died [7], but was considered an accidental host [8–10]. Neither the natural host nor the com-
plete host range of EHV-9 is known, but EHV-9 causes lethal disease in a number of different
species under experimental conditions [3, 7, 10–13]. Both EHV-1 and/or EHV-9 have been
shown to infect species in captivity other than their known natural hosts, resulting in disease
and fatality in non-perissodactyla species such as polar bear (Ursus maritimus), black bear (U.
americanus), llamas (Lama glama), alpacas (Vicugna pacos), blackbuck (Antelopa cervicapra),
Thomson’s gazelle (Gazelle thomsoni) and giraffe (Giraffa camelopardalis) [7, 12, 14–18]. A
recombinant zebra-EHV-1/EHV-9 infection was reported in a polar bear and in Indian rhinoc-
eros (Rhinoceros unicornis), in both cases resulting in severe and ultimately fatal neurological
symptoms [19, 20]. The complete host range of EHV-1 and EHV-9 and whether there are dif-
ferences in captivity that potentially promote cross-species transmission remains unknown.
Serological studies conducted on free-living zebra populations (Equus burcelli) have demon-
strated the presence of antibodies against EHV-1 and EHV-4 in South Africa and against
EHV-9 in Tanzania where zebras share water sources and grazing areas with Thomson’s
gazelles and are thus frequently in close proximity to each other [3, 21, 22]. In Tanzania, the
seroprevalence of EHV-1 and EHV-9 infections of 14% and 60%, respectively, was surveyed by
serum neutralization test (SNT) [3]. However, equid alphaherpesviruses are very similar genet-
ically and antigenetically; thus, SNT’s have poor discriminatory power for closely related
viruses such as EHV-1, EHV-4 and EHV-9. Therefore, it is unlikely that SNT’s allow discrimi-
nation between EHV-1 or EHV-9 antibodies [7, 10].
To accurately distinguish between the different virus strains, a type-specific-gG-based
enzyme-linked immunosorbent assay (ELISA) was developed for EHV-1- and EHV-4-specific
antibodies [23]. ELISAs were also developed to discriminate between EHV-1 and EHV-4 using
peptides [glycoprotein E (gE) for EHV-1 and glycoprotein G (gG) for EHV-4] [24, 25]. How-
ever, assays to discriminate antibodies against EHV-1 and EHV-9 have not been developed.
In this study we developed and applied a peptide-based ELISA to detect and differentiate
between EHV-1- and EHV-9-specific antibodies in serum of different species. Seroprevalence
for both viruses was determined from 428 serum samples collected from captive and wild ani-
mals. The objectives of the study were to determine the prevalence of EHV-1 and EHV-9 infec-




Sera were collected from non-vaccinated captive (n = 277 samples from 43 zoos) and free rang-
ing species (n = 151 samples, Tanzania and Namibia) (Table 1). EHV-9 positive serum col-
lected from an experimentally infected rabbit [26] was used as a positive control as no infected
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Table 1. List of animal species and number of serum samples used in this study.
Zoo serum samples
Order/Family/species/ subspecies Number Origin Place of birth
Perissodactyla Odd-toed ungulates
Equidae Captive Captive
Equus quagga antiquorum Damara zebra 6
Equus quagga boehmi Grant’s zebra 32
Equus quagga chapmani Chapman's zebra 1
Equus grevyi Grévy's zebra 17
Equus zebra hartmannae Hartmann's mountain zebra 33
Equus kiang Kiang 3
Equus ferus caballus Pony 4
Equus hemionus onager Onager 5
Equus africanus asinus Donkey 12
Equus africanus somalicus Somali wild ass 19
Rhinocerotidae Captive Captive
Ceratotherium simum White rhinoceros 64 26 captive
36 wild
2 unknown
Diceros bicornis Black rhinoceros 6 Captive
Artiodactyla Even-toed ungulates Captive Captive
Bovidae
Tragelaphus imberbis Lesser kudu 13
Hippotragus niger Sable antelope 12
Kobus megaceros Nile lechwe 7
Addax nasomaculatus Addax antelope 2
Taurotragus oryx Common eland 2
Ovibos moschatus Muskox 1
Girafﬁdae
Giraffa camelopardalis Giraffe 10
Okapia johnstoni Okapi 8
Cervidae
Alces alces alces Moose 1
Hippopotamidae
Hippopotamus amphibious Hippopotamus 1
Carnivore Captive Captive
Ursidae
Ursus maritimus Polar bear 7
Ursus thibetanus Asian black bear 8
Felidae
Panthera leo krugeri White lion 1
Primates Captive Unknown
Cercopithecidae
Papio hamadryas Hamadryas baboon 1




Equus quagga Plain zebra 41 40 Tanzania
(Continued)
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horse serum was available. An EHV-9 negative horse (umbilical cord blood serum) [24] sample
was used as a negative control. An EHV-1-positive control serum collected at day 21 from an
experimentally infected seronegative horse (horse a [24, 27]) and EHV-1-negative control
(umbilical cord blood serum) collected from equine neonates immediately after birth [24] were
used as controls for EHV-1 infection. Fetal calf serum was used as a negative control for SNT.
Ethics statement
The described research was approved by the Internal Ethics Committee of the Leibniz-institute
for Zoo and Wildlife Research (IZW), Approval no. 2012-05-02.
Serum neutralization test
Serum neutralization test (SNT) was performed as described in the OIE Manual of Diagnostic
Tests and Vaccines for Terrestrial Animals with few modifications [3, 28]. Briefly, in 96-well
micro plates, serial two fold dilutions of complement-inactivated serum samples at 56°C for 30
min were incubated with 100 plaque forming units (PFU)/100μl of EHV-1 or EHV-9 at 37°C.
After 1 h incubation, 5×105 equine dermal cells (ED) were added and incubated for 2 h at
37°C. The wells were overlaid with 1.6% (w/v) methylcellulose medium and incubated at 37°C.
The reaction was stopped after 4 days with 3% (v/v) formalin and the plaques were stained
with Giemsa. EHV-1-positive horse serum and fetal calf serum were included as positive and
negative controls, respectively. In the case of EHV-9, positive rabbit serum and fetal calf serum
were included as positive and negative controls, respectively. SN antibody titers were calculated
by determining the highest serum dilution that completely protects the monolayers from infec-
tion (no CPE) in each well. Titers of 1:4 were considered as positive. Each test was validated




Order/Family/species/ subspecies Number Origin Place of birth
1 Namibia
Rhinocerotidae
Diceros bicornis Black rhinoceros 17 Namibia
Artiodactyla Namibia Wild
Bovidae
Antidorcas marsupialis Springbok 20
Connochaetes gnou Black wildebeest 22
Carnivore Namibia Wild
Felidae
Panthera leo Lion 17
Canidae
Lycaon pictus African wild dog 6
Canis mesomelas Black-backed jackal 10
Hyaenidae
Crocuta crocuta Spotted hyaena 8
Proboscidea Namibia Wild
Elephantidae
Loxodonta africana African elephant 10
doi:10.1371/journal.pone.0138370.t001
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Peptides
Two sets of peptides, 18 amino acids (KQPQPRLRVKTPPPVTVP) for EHV-1_E (1E) and 15
amino acids (DSPPETPSPQENLND) for EHV-9_G (9G), that were biotinylated at the N-ter-
minus and attached to two aminohexanoic acid hydrophobic spacers, to be able to attach to the
streptavidin coated microtitre plates, were synthesized (Genscript, USA). The EHV-1_E pep-
tide was used for descrimination between EHV-1 and EHV-4 as described previously [24].
EHV-9_G has shared 40% and 33% amino acid identity with gGs of EHV-1 horse strain (Gen-
Bank accession number: AET80923.1) and EHV-1 zebra strain (GenBank accession number:
AII81244.1), respectively and was used to differenciate between EHV-1 and -9.
An EHV-1_G peptide (ESSLENQLTQEESNN), was tested with EHV-1 and EHV-9- posi-
tive and negative controls to confirm the specificity of the selected EHV-9_G peptide (Gen-
Bank accession number: AII81244.1).
Peptide-based ELISA
The ELISA test was carried out on equids as described previously [24, 29] with few modifica-
tions. Briefly, 96-well plates (Sarstedt, Germany) were coated to 100 μl/well with 1μg/ml strep-
tavidin dissolved in 50 nM carbonate-biocarbonate buffer (PH 9.6) overnight at 4°C. The wells
were washed three times with PBS (PH 7.5) containing 0.1% (v/v) Tween 20 (PBST). After
coating with 100 μl /well of the respective biotinylated peptide (2 μg/ml in 50 nM carbonate-
biocarbonate buffer), the plates were incubated for 2 h at 37°C. Unoccupied sites were blocked
by incubation for 1 h at 37°C with 1% (v/v) goat serum diluted in PBST. After washing, serum
samples (100 μl/well) were added in dilution of 1:400 and incubated for 1 h at 37°C. Purified
goat anti-horse IgG conjugated with horseradish peroxidase (1:20000; Dianova, Germany),
and HRP-goat anti-rabbit IgG for the EHV-9 positive control (1:10000; cell signaling, Ger-
many) was added to each well. After 1 h incubation and washing, the plates were developed
with 100 μl/well TMB [3,3_,5,5_-tetramethylbenzidine; dissolved in 42 μg/ml citric acid, 0.01%
(v/v) H2O2 (pH 3.95)]. The reaction was stopped after 10 min with 100 μl/ml of 1 M sulfuric
acid and the plates were read at a wavelength of 450 nm on a spectrophotometer. Each serum
sample was tested for significant EHV-1 and EHV-9 antibody titers at three independent
times. Negative and positive serum controls were included in each plate.
Secondary antibody choice can be critical in serological analysis of different wildlife species
[30]. For detection of EHV-1 and EHV-9 antibodies in different mammalian sera, the ELISA
test was performed as described above except a 2% (w/v) albumin fraction was used as blocking
buffer and protein G-peroxidase conjugate (1:10,000; Invitrogen, Germany) was used as a sec-
ondary antibody [30]. Protein G-peroxidase was shown to be capable of binding to the Fc
region of immunoglobulin (IgG) without interfering with the antigen binding sites [30]. The
protein G-peroxidase-dilution was optimized using 10 positive and 10 negative randomly
selected zebra sera, based on our peptide-ELISA results. All negative samples yielded negative
results with protein G-peroxidase and positive serum samples yielded the expected optical den-
sity (OD) values (S1 Fig). As controls, EHV-1 (wild zebra, PZ27) or EHV-9 (wild zebra, PZ34)
positive zebra serum samples were used as a positive control. For testing carnivore serum sam-
ples, recombinant HRP-labeled protein A/G (1:10000; Thermo scientific, USA) was used [30].
Assay sensitivity and specificity determination
The cutoff value is defined as the level of antibody activity which represents a minimum posi-
tive status for a tested animal. The method for determining a diagnostic cutoff is to test samples
from known negative and positive populations [31]. In a previous study [24], the negative cut-
off value for the EHV-1_E peptide was calculated based on data from 9 negative umbilical cord
Prevalence of EHV-1 and -9 in Captive andWild Animals
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sera and 26 Icelandic horses sera, which were known to be immunologically naive to EHV-1.
Due to the lack of specific pathogen free zebras and no EHV-1- or EHV-9-experimentally
infected zebras, we used 27 zoo zebra sera (12 plains zebra, 9 Hartmann’s mountain zebra, and
6 Grevy’s zebra), which were free from detectable neutralizing antibodies against either EHV-1
or EHV-9 as tested by SNT (S1 Table), to calculate the negative cutoff value. A negative cutoff
was calculated as the mean OD of zebra sera plus 2 SD and a positive cutoff was calculated as
mean OD of this population plus 3 SD [24]. The cutoff values were applied to the non-equid
samples as well because control serum and numbers of samples were insufficient to make an
equivalent determination as with zebras and protein G peroxidase was shown not to interfere
with the assay. The cutoff is conservative (mean OD plus or minus 2 to 3 SD) and it is more
likely that some non-equids that were weakly positive were scored as negative than scoring ani-
mals as false positives.
Statistical analysis
All statistical analyses and graphs were performed using GraphPad Prism version 5.0a software
(GraphPad Software, San Diego, CA). Fisher tests were used to compare the frequencies or pro-
portions of EHV-1 and -9 positivity. Differences were considered statistically significant when
the P value was less than 0.05.
Results
Peptide ELISA sensitivity and specificity
EHV-1 gE (EHV-1_E)- and EHV-9 gG (EHV-9_G)- peptides were used to differentiate
between EHV-1- and EHV-9-specific antibodies. To test the reactivity and specificity of the
selected EHV-9_G peptide, an EHV-9-positive rabbit serum and different positive and negative
EHV-1 horse sera were used. The peptide produced high OD values (1.26) with an EHV-9-pos-
itive control serum and no reaction with EHV-1-positive (OD = 0.06) or EHV-9-negative
(OD = 0.04) horse serum controls (MannWhitney test, P = 0.002; Fig 1A).
The reactivity and specificity of the EHV-1_E peptide was previously determined [24]. The
peptide produced high OD values (1.49) with an EHV-1-positive control, an OD value of 0.52
with the EHV-9-positive control and a low OD value (0.05) with EHV-1-negative controls.
Although there was a significant difference between EHV-1- and EHV-9-positive controls
(MannWhitney test, P = 0.002; Fig 1B), this result did not unequivocally differentiate between
EHV-1 and EHV-9 as the OD value of EHV-9-positive control was above the negative cutoff.
An EHV-1_E peptide was used to detect EHV-1-positive antibodies, particularly in EHV-
9-negative samples, and to exclude EHV-4 (a more distantly related virus to EHV-1 and EHV-
9) infection [24].
To examine the specificity of the EHV-9_G peptide, EHV-1 and EHV-9 positive and nega-
tive controls were tested with a peptide with the EHV-1 gG sequence. The peptide produced
OD values (0.4) with an EHV-1-positive control serum and OD = 0.15 with EHV-9-positive
control and no reaction with EHV-9-negative (OD = 0.04) control (MannWhitney test,
P = 0.02; Fig 1C). Although it demonstrated a clear EHV-1 specificity, we did not rely on this
peptide to discriminate the EHV-1 positive serum samples due to low reactivity with the EHV-
1 positive control in comparison with the EHV-1_E peptide.
To determine the cutoff value, 27 zoo zebra sera were tested. The serum samples were con-
sidered EHV-1-positive when the OD value was higher than 0.2 and negative when the OD
value was lower than 0.18. For EHV-9, serum samples were considered positive when OD val-
ues exceed 0.14 and negative when below 0.13. OD values between 0.18 and 0.2 in case of
EHV-1 and between 0.14 and 0.13 in case of EHV-9 were considered questionable and may
Prevalence of EHV-1 and -9 in Captive andWild Animals
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Fig 1. Reactivity and specificity of EHV peptides.Reactivity and specificity of (A) EHV-9_G (9G), (B) EHV-
1_E (1E), and (C) EHV-1_G (1G) peptides using EHV-1 (PC1) (serum collected at day 21 from
experimentally infected horse), EHV-9 (PC9) positive controls (rabbit serum) and NC (umbilical cord blood
serum). The dashed line represents the negative cutoff value.
doi:10.1371/journal.pone.0138370.g001
Prevalence of EHV-1 and -9 in Captive andWild Animals
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represent antibody levels that are either very low (at the detection limit) or non-specific cross
reactions (Fig 2A and 2B). Three samples were tested positive for EHV-1, while one sample
was tested positive for EHV-9.
Detection of EHV-1 and EHV-9 neutralizing antibodies
None of the animals tested (Table 1), wild or captive, were noted to have displayed clinical
symptoms including lesions associated with herpesvirus infection. Of 132 sera from equids in
captivity, 60 and 59 were seropositive by SNT for EHV-1 and EHV-9, respectively (Table 2). In
wild plains zebra serum samples (n = 41), 32 and 35 tested positive for EHV-1 and EHV-9,
respectively (Table 2). The samples collected from captive kiangs, onagers or ponies (n = 12)
were negative for antibodies against both viruses. Out of 64 captive white rhinoceros sera, 9
and 26 were positive by SNT for EHV-1 and EHV-9 antibodies, respectively. Captive black rhi-
noceros serum samples (n = 6) did not show neutralizing antibodies against EHV-1 or EHV-9.
In wild black rhinoceros, one and two out of 17 animals were positive for EHV-1 and -9 anti-
bodies, respectively (Table 2). None of the tested captive or wild non-equid sera tested positive
for either virus, except for one captive antelope [lesser kudu (Tragelaphus imberbis)], which
had a low antibody titer for EHV-9 (Table 2). In the current study, neutralizing antibodies for
either EHV-1 or EHV-9 were not detected in any of the tested carnivore serum samples (cap-
tive: n = 16; wild: n = 41; Table 1).
Discrimination between EHV-1- and EHV-9- antibodies by peptide-
based ELISA
All sera were tested by ELISA using EHV-1_E and EHV-9_G specific peptides (Table 1). In
captive plains zebras, 22 and 10 serum samples tested positive for EHV-1 and EHV- 9 antibod-
ies, respectively (n = 39; Fig 3A and 3B), 6 samples were classified as questionable for EHV-1,
and one sample was questionable for EHV-9 antibodies. In wild plains zebras, 33 serum sam-
ples tested positive for EHV-1 exposure and 14 serum samples were positive for EHV-9 anti-
bodies. The OD values in captive plains zebra were generally lower than those found in wild
plains zebras (n = 41; Fig 3C and 3D). In captive Grevy’s zebra, fewer (11 and 8 serum samples,
respectively, were positive for EHV-1 and EHV-9 (n = 17, Fig 4A and 4B). In captive Hartman
mountain zebra 22 and 8 samples were positive for EHV-1 and EHV-9 antibodies, respectively
(n = 33, Fig 5A and 5B). The data showed that the prevalence of EHV-1, but not EHV-9,
antibodies in wild plains zebras was significantly higher than that in captive plains zebras
(P = 0.02; Fisher’s exact test). There was no significant difference in EHV-1 (P = 0.6; Fisher’s
exact test) and EHV-9 (P = 0.2; Fisher’s exact test) prevalence between the three tested captive
zebra species.
Similar to the SNT results, onagers, ponies, and kiangs were negative for both EHV-1 and
EHV-9 antibodies as detected with the ELISAs. Four donkeys tested positive (n = 12) for EHV-
1 antibodies. In Somali wild asses, 14 samples were positive for EHV-1 antibodies and one was
positive for EHV-9 antibodies (n = 19, Fig 6A and 6B). The prevalence of EHV-1 antibodies in
the tested plains zebra (wild or captive), captive Hartmann’s zebra, and captive Somali wild ass
sera was significantly higher than that of EHV-9 (P< 0.0001; Fisher’s exact test).
Out of 64 captive white rhinoceros sera, 20 serum samples tested positive for EHV-1 expo-
sure and 42 tested positive for EHV-9 antibodies (Fig 7A and 7B). One of 6 tested captive black
rhinoceroses’ serum samples was positive for EHV-9 antibodies (Fig 7C and 7D). In wild Afri-
can black rhinoceros, 7 serum samples tested positive for EHV-1 exposure and 12 were positive
for EHV-9 (n = 17, Fig 7E and 7F). The number of white rhinoceroses with exposure to EHV-9
was significantly higher than that with exposure to EHV-1 (P<0.05; Fisher’s exact test).
Prevalence of EHV-1 and -9 in Captive andWild Animals
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Although the prevalence of EHV-9 antibodies was higher than that of EHV-1 in black rhinoc-
eros (either wild or captive), we could not detect a significance difference after statistical analy-
sis, which may be due to the small sample size. Moreover, the prevalence of the detected EHV-
9 antibodies was significantly higher in the complete tested rhinoceros population than the
zebra population, in both captive and wild animals, (P<0.05; Fisher’s exact test).
The only EHV-9-positive captive antelope serum sample tested positive by SNT was con-
firmed as positive by ELISA. In addition, two free-ranging springboks (Antidorcas marsupialis)
were weakly positive for EHV-9 antibodies but that was only evident in the ELISA (Fig 8).
None of the other animal families (Giraffidae, Cervidae,Hippopotamidae, Cercopithecidae,
Elephantidae) tested positive for antibodies to either virus. We were unable to test for EHV-1
and EHV-9 antibodies in carnivores by ELISA (Ursidae, Felidae, Canidae,Hyaenidae) due to
the high cross-reactivity of the protein A/G secondary antibody. The numbers of positive
serum samples for each species are listed in details in Table 3.
Fig 2. Determination of cutoff value. Twenty seven zebra serum samples were tested with either (A) EHV-
9_G or EHV-1_E (B) peptides. OD values above the black line are considered positive, while OD values
below the dashed line are considered negative. OD values between the lower and upper cut-offs were
considered as questionable.
doi:10.1371/journal.pone.0138370.g002
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Molecular finding
Out of 17 wild African black rhinoceros samples, 3 blood samples were available in addition to
serum. DNA was extracted and a nested PCR amplification of a partial sequence of the DNA-
dependent-DNA polymerase gene was applied [20, 32]. A 250 bp fragment was amplified from
one sample. Sanger sequencing revealed a sequence with 94% homology to the novel gamma-
herpesviruses sequence described from Damara’s zebra (E. burchellii antiquorum), Somali wild
ass (E. asinus somalicus), and eastern kiang (E. kiang holdereri) [12] (data not shown).
Discussion
None of the animals that tested positive for antibodies to either virus exhibited clinical symp-
toms indicative of herpesvirus infection. This is characteristic of natural viral host species and
may be suggestive of co-adaptation of species that are natural conspecifics of equid reservoir
animals. Serological analysis was undertaken because latency, the hallmark of herpesvirus
infection, would probably underestimate the prevalence based on presence of viral antigen or
nucleic acid. Furthermore, serological assays can be used for detection of possible reservoir
hosts as described previously [33]. EHV-1 and EHV-9 share high nucleotide sequence similar-
ity, the overall difference of their complete genome sequences being 9% [7]. As a result of this
high degree of similarity, it is difficult to distinguish EHV-1 from EHV-9 serologically. SNT is
known to be a sensitive and robust test, but may not accurately discriminate between similar
viruses [34]. The limitations are well known for discrimination of EHV-1 and EHV-4, which
share much less antigenic similarity compared to the EHV-1 and EHV-9 pair. Nonetheless, it
is impossible to distinguish between EHV-1 and EHV-4 by SNT [24]. The epidemiological
data of equine herpesviruses in zoo and wildlife is very limited and based on SNT [3, 21]. As an
illustration of the problems associated with exclusive reliance on SNT, we found that 26 of 59
equid sera, which tested positive for EHV-9 by SNT, were negative by ELISA, results indicating
that the detected serum neutralizing EHV-9 antibodies were a result of cross-reactivity with
EHV-1. In contrast, peptide-ELISA has been successfully applied as a specific and sensitive
serological test for detection of EHV-1 and EHV-4 seroprevalence [24]. A recent study also
Table 2. Equine herpesvirus-antibody positive rates in captive and wildlife sera using SNT.
Number (%) of positive results
Family/ animal Total EHV-1 EHV-9
Captive sera
Equidae
Plains zebra 39 24 (61.5%) 21 (53.8%)
Grevy's zebra 17 9 (52.9%) 9 (52.9%)
Hartmann's mountain zebra 33 10 (30.3%) 15 (45.4%)
Donkey 12 4 (33.3%) 3 (27.2%)
Somali wild ass 19 13 (68.4%) 11 (57.8%)
Rhinocerotidae
White rhinoceros 64 9 (14.0%) 26(40.6%)
Bovidae 37 0 (0.0%) 1 (2.7%)
Wild sera
Equidae
Plains zebra 41 32 (78%) 35 (85.3%)
Rhinocerotidae
Black rhinoceros 17 1 (5.8%) 2 (11.7%)
doi:10.1371/journal.pone.0138370.t002
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Fig 3. EHV antibodies in plains zebra.OD values of antibody responses tested by peptide-based ELISA in captive (A and B) and wild (C and D) plains
zebra using EHV-1_E (A and C) and EHV-9_G (B and D) peptides. Black line: cutoff above which samples are considered positive. PC1 = EHV-1 positive
control (serum collected at day 21 from experimentally infected horse), PC9 = EHV-9 positive control (serum collected from an experimentally infected
rabbit), NC = negative control (umbilical cord blood serum), PZ = plains zebra.
doi:10.1371/journal.pone.0138370.g003
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demonstrated that ELISA was more sensitive than SNT in detection of EHV-1 antibodies in
milk [35]. ELISA tests, particularly when using strain specific peptides, are more discriminating
and sensitive than SNT.
While the EHV-9_G peptide was highly specific and could accurately discriminate the
EHV-9 infected animals, the EHV-1_E peptide cross reacted with EHV-9 positive samples.
With all EHV-1-positive but EHV-9-negative serum samples, OD values considered positive
were obtained with the EHV-1_E peptide, while OD values with the EHV-9_G peptide were
negative. Many of the serum samples testing positive for EHV-9 were also positive for EHV-1.
Whether this represents cross reaction or co-infection in the given serum samples is unclear.
However, the EHV-1_E peptides allowed the exclusion of EHV-4 infection [24]. While this
does present some limitations in determining the specific exposure status of the animals exam-
ined, the results provide a much higher resolution determination of infection history, particu-
larly for EHV-9, than was previously possible for such genetically similar viral strains.
Fig 4. EHV antibodies in captive Grevy’s zebra.OD values of antibody responses tested by peptide-based
ELISA in captive Grevy’s zebra using EHV-1_E (A) and EHV-9_G (B) peptides. Black line: cutoff above which
samples are considered positive. PC1 = EHV-1 positive control (serum collected at day 21 from
experimentally infected horse), PC9 = EHV-9 positive control (serum collected from an experimentally
infected rabbit), NC = negative control (umbilical cord blood serum), GZ = Grevy’s zebra.
doi:10.1371/journal.pone.0138370.g004
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Sampling was undertaken with two goals in mind. The first was to sample as many zebras as
possible, both captive and wild to determine the prevalence of EHV-1 and EHV-9 in the pre-
sumptive host for both viruses. The second goal was to sample African con-specifics of zebras
as broadly as possible to determine the range of species potentially infected rather than focus-
ing on any one species. Peptide-based ELISA demonstrated that the prevalence of EHV-1 anti-
bodies in equids (wild or captive plains zebra, captive Hartmann’s zebra, and captive Somali
wild ass) was significantly higher than that of EHV-9. However, due to the cross reactivity of
EHV-9 positive antibodies with the EHV-1_E peptide, further study will be needed to confirm
the results obtained or refine the discriminatory power of the ELISA. These results strongly
suggest that these equid species are a natural and definitive host for EHV-1. There was no sig-
nificant difference in EHV-1 and EHV-9 prevalence between the three tested zebra species.
The results were not influenced by zebra species, thus all zebras exhibited very similar preva-
lence. While wild Hartmann’s zebra and Somali wild ass sera were not available for this study,
the lack of significant difference between wild and captive plains zebra and any plain zebra to
the other equids suggests a similar prevalence could be expected in the wild for these species.
EHV-1 and EHV-9 infections were reported previously in onager and pony [36, 37]; however,
we could not detect antibodies for any of the viruses in these species, which might be due to the
Fig 5. EHV antibodies in captive Hartmann's mountain zebra.OD values of antibody responses tested by peptide-based ELISA in captive Hartmann's
mountain zebra using EHV-1_E (A) and EHV-9_G (B) peptides. Black line: cutoff above which samples are considered positive. PC1 = EHV-1 positive
control (serum collected at day 21 from experimentally infected horse), PC9 = EHV-9 positive control (serum collected from an experimentally infected
rabbit), NC = negative control (umbilical cord blood serum), MZ = Hartmann's mountain zebra.
doi:10.1371/journal.pone.0138370.g005
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low sample size. In contrast, both EHV-1- and EHV-9-specific antibodies were detected in
Somali wild asses. EHV-1 antibodies have been detected in Somali wild asses [18], however this
is the first report of EHV-9 antibodies in this species. Recombination between EHV-1 and
EHV-9 has been observed in sequences isolated from polar bear and Asian rhinoceros [19, 20].
The co-occurrence of these viruses in equids suggests that closely related equid alphaherpes-
viruses have natural opportunities to recombine and help explain the origin of recombinant
isolates.
Using the developed peptide ELISA, an unexpectedly high prevalence of EHV-9 antibodies
among captive and free-living African rhinoceros species was observed, the inverse of the
observed prevalence in zebras, which exhibited higher EHV-1 antibody prevalence. However,
EHV-1 antibodies were detected in larger number of rhinoceroses when compared to a previ-
ous study that relied exclusively on the immunofluorescence assay illustrating the higher sensi-
tivity and specificity of the peptide based ELISA developed here [5]. The unexpectedly high
prevalence of EHV-9 antibodies in rhinoceroses (particularly, captive white rhinoceros) sug-
gests they are susceptible to EHV-9 infection and may serve as a natural and possibly definitive
host or reservoir. The question of the natural reservoir and definitive host is particularly impor-
tant for EHV-9 as the source of the many fatal infections of ungulates under natural conditions
was not identified. Both EHV-1 and EHV-9 have been involved in fatal encephalitis cases in
Fig 6. EHV antibodies in other captive equid species.OD values of antibody responses tested by peptide-based ELISA in other captive equid species
using EHV-1_E (A) and EHV-9_G (B) peptides. Black line: cutoff above which samples are considered positive. PC1 = EHV-1 positive control (serum
collected at day 21 from experimentally infected horse), PC9 = EHV-9 positive control (serum collected from an experimentally infected rabbit),
NC = negative control (umbilical cord blood serum), ES = Equus africanus somalicus (Somali wild ass), EA = Equus africanus asinus (donkey), EO = Equus
hemionus onager (onager), EC = Equus ferus caballus (pony), EK = Equus hemionus kiang (kiang).
doi:10.1371/journal.pone.0138370.g006
Prevalence of EHV-1 and -9 in Captive andWild Animals
PLOS ONE | DOI:10.1371/journal.pone.0138370 September 17, 2015 14 / 20
Fig 7. Prevalence of EHV-1 and EHV-9-antibodies in captive and wild rhinoceroses.OD values of antibody responses tested by peptide-based ELISA in
captive white (A-B), black (C-D) and wild black (E-F) rhinoceroses using EHV-1_E (A, C, E) and EHV-9_G (B, D, F) peptides. Black line: cutoff above which
samples are considered positive. PC = positive control (PZ27w) for EHV-1 and (PZ34w) for EHV-9, NC = negative control (umbilical cord blood serum),
R = white rhino, BR = black rhino.
doi:10.1371/journal.pone.0138370.g007
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Fig 8. EHV antibodies in captive and wild antelopes.OD values of antibody responses tested by peptide-
based ELISA in captive and wild antelope using EHV-9_G peptide. Black line: cutoff above which samples
are considered positive. PC = positive control, PZ34w, NC = negative control (umbilical cord blood serum),
SB = springbok, LK = lesser kudu.
doi:10.1371/journal.pone.0138370.g008
Table 3. Equine herpesvirus-antibody positive rates in captive and wildlife sera using peptide-based
ELISA.
Number (%) of positive results
Family/ animal Total EHV-1 EHV-9
Captive sera
Equidae
Plains zebra 39 22 (56.4%) 10 (25.6%)
Grevy's zebra 17 11 (64.7%) 8 (47%)
Hartmann's mountain zebra 33 22 (66.6%) 8 (24.2%)
Donkey 12 4 (33.3%) 0 (0.0%)
Somali wild ass 19 14 (73.6%) 1 (5.2%)
Rhinocerotidae
White rhinoceros 64 20 (31.2%) 42 (65.6%)
Black rhinoceros 6 0 1 (16.6%)
Bovidae 37 0 1 (2.7%)
Wild sera
Equidae
Plains zebra 41 33 (80.4%) 14 (34.1%)
Rhinocerotidae
Black rhinoceros 17 7 (41.1%) 12 (70.5%)
Bovidae 42 0 (0.0%) 2 (4.7%)
doi:10.1371/journal.pone.0138370.t003
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captive polar bears without proximity to equids [12, 19]. Rhinoceroses, which were not consid-
ered a potential source of infection, may have been involved in these unexplained transmission
events. Similarly, a recent Asian rhinoceros fatality as a consequence of EHV-1 infection was
suspected from a zebra source but may have derived from African rhinoceros [20]. Mammals in
many African ecosystems congregate at water sources during periods of seasonal water shortage,
which may explain transmission of viruses among perissodactyls and non-perissodactyls. For
example, EHV-9 antibodies were detected in one captive lesser kudu and two wild springbok by
SNT and/or ELISA. The low prevalence of EHV-9-positive antelopes as well as the previous
fatal EHV-9 infection [7] supports the hypothesis that these species are accidental hosts of the
virus. In addition to the serological evidence, the detection of zebra isolated equine gammaher-
pesviral DNA in one wild black rhinoceros blood sample illustrates that transmission of EHVs
does occur within African ecosystems. The general lower OD values observed for zebras and rhi-
noceros in captivity likely represents lower exposure, re-exposure and viral reactivation in cap-
tivity similar to the observe loss of pathogens in mice after generations of captivity [38].
Carnivores can be infected with EHV-1 and/ or EHV-9 either experimentally as in dogs and
cats causing neurotropic encephalitis and death [39, 40] or naturally in captive polar bears
which died after displaying severe nervous manifestations [12, 19]. Neither EHV-1 nor EHV-9
was detected in any carnivore sample in the current study by SNT. However, ELISA could not
be applied due to non-specific cross reaction with protein A/G. Nonetheless, our findings sug-
gest that carnivores are less frequently infected by EHV or fail to seroconvert and based on
experimental infection, may be more likely to exhibit neurological symptoms when infection
does occur. African carnivores, many of which prey on or scavenge equids may have evolved
resistance to EHV as a result of the high risk of exposure to infection. Polar bears and non-Afri-
can carnivores would not be expected to have evolved such resistance which may explain the
relatively frequent observed fatal disease in species that are not naturally sympatric with Afri-
can Perissodactyls.
Taken together, we propose that EHV-1 and EHV-9 have evolved a broad host range
among African mammals including distantly related perissodactyls. The results presented here
show that different families including Equidae, Rhinocerotidae and Bovidae, respond with
robust antibody responses to EHV-1 and EHV-9 exposure. The high prevalence in the Rhino-
ceroteridae in particular, suggests that they may be a natural host and/or reservoir for EHV-9.
Further study is needed to determine the role of these animals in EHV epidemiology in both
captivity and the wild.
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